A functional, multi-organ, serum-free system to culture P. falciparum—a protozoan that typically causes severe and fatal malaria—in order to establish innovative platforms for the development of therapeutic drugs was developed by Michael J. Rupar and a team of researchers at Hesperos Inc. in Florida, U.S. For the purpose of simulating an infection, the platform contained four human organ constructs, including hepatocytes, splenocytes, endothelial cells, and recirculating blood cells. The group utilized two types of P. falciparum: the 3D7 strain, delicate to chloroquine, a deep-rooted enemy of malarial medication, and the W2 strain, safe to chloroquine. They kept up with practical